Protagenic Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: PTIXW · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: PTIX
TL;DR
PTIX filed an 8-K for a shareholder vote - details to come.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on April 18, 2025, reporting a submission of matters to a vote of security holders. The company, previously known as Atrinsic, Inc., is incorporated in Delaware and its fiscal year ends on December 31st. The filing does not contain specific financial figures or details about the matters to be voted upon.
Why It Matters
This filing indicates that Protagenic Therapeutics is seeking shareholder approval for certain corporate actions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial risks or significant operational changes.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- Atrinsic, Inc. (company) — Former company name
- April 18, 2025 (date) — Filing date
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted upon, only that such a submission has occurred.
When was Protagenic Therapeutics, Inc. incorporated?
The company is incorporated in Delaware, as indicated by the filing.
What is the fiscal year end for Protagenic Therapeutics, Inc.?
The fiscal year end for Protagenic Therapeutics, Inc. is December 31st.
Has Protagenic Therapeutics, Inc. undergone previous name changes?
Yes, the company was formerly known as Atrinsic, Inc., NEW MOTION, INC., and MPLC, Inc.
What is the primary business of Protagenic Therapeutics, Inc.?
The company is classified under Pharmaceutical Preparations (SIC code 2834).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).